Get the Stockscreener App
60.73
6.39%
3.65
After Hours:
60.73
Conmed Corp Stock (CNMD) Forecast
The Conmed Corp (CNMD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $40.33, representing a -33.59% decrease from the current price of $60.73. The highest analyst price target is $65.79, and the lowest is $14.86.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNMD Price Target
Average 64.28
(+5.85% Upside)
Is Conmed Corp (CNMD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.73 | Neutral |
| STOCH(9,6) | 76.22 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.7772 | Buy |
| ADX(14) | 25.78 | Buy |
| William %R | -2.7581 | Sell |
| CCI(14) | 116.33 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
55.96
Buy
|
56.31
Buy
|
| MA20 |
52.68
Buy
|
55.07
Buy
|
| MA50 |
56.23
Buy
|
56.71
Buy
|
| MA100 |
61.93
Sell
|
60.38
Buy
|
| MA200 |
66.12
Sell
|
65.58
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, CNMD could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on CNMD, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.73 indicates that CNMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 76.22 indicates that CNMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CNMD is oversold. This suggests that CNMD price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.78 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 116.33 indicates that CNMD is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CNMD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Conmed Corp financial reports and earnings history, Conmed Corp (CNMD) stock could reach $316.34 by 2030, $1,144.61 by 2040 and $2,099.96 by 2050. See the projected annual prices until 2050 of the Conmed Corp stock below:
- Conmed Corp (CNMD) is expected to reach an average price of $934.08 in 2035, with a high prediction of $932.87 and a low estimate of $491.29. This indicates an $1,438% rise from the last recorded price of $60.73.
- Conmed Corp (CNMD) stock is projected to chart a bullish course in 2040, with an average price target of $1,088.49, representing an $1,692% surge from its current level. The forecast ranges from a conservative $1,090.70 to a sky-high $1,144.61.
- Our analysts predict Conmed Corp (CNMD) to jump 1,692% by 2045, soaring from $1,089.65 to an average price of $1,088.18, potentially reaching $1,134.60. While $1,089.65 is the low estimate, the potential upside is significant.
- Conmed Corp (CNMD) stock is expected to climb by 2050, reaching an average of $1,994.51, a $3,184% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2,099.96 and $1,996.85, respectively, highlighting the market's uncertainty.
Conmed Corp Stock (CNMD) Year by Year Forecast
Conmed Corp Stock (CNMD) Price Forecast for 2025
Conmed Corp Stock (CNMD) is expected to reach an average price of $35.92 in 2025, with a high prediction of $71.63 and a low estimate of $0.2036. This indicates an -40.86% fall from the last recorded price of $60.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $17.08 | $14.86 | $65.79 | -71.88% |
| July, 2025 | $65.72 | $19.41 | $71.63 | +8.21% |
| August, 2025 | $53.99 | $56.24 | $59.43 | -11.10% |
| September, 2025 | $46.41 | $46.56 | $42.89 | -23.59% |
| October, 2025 | $31.62 | $38.08 | $40.53 | -47.93% |
| November, 2025 | $3.0306 | $9.6806 | $21.70 | -95.01% |
| December, 2025 | $8.9587 | $3.1033 | $14.53 | -85.25% |
Conmed Corp Stock (CNMD) Price Forecast for 2026
The predicted value for Conmed Corp (CNMD) in 2026 is set at an average of $92.14. Estimates vary from a peak of $179.29 to a trough of $5.0008, indicating an +51.73% surge from the present price of $60.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.62 | $5.0008 | $30.74 | -74.27% |
| February, 2026 | $126.67 | $12.51 | $125.46 | +108.58% |
| March, 2026 | $106.86 | $108.32 | $117.03 | +75.96% |
| April, 2026 | $93.19 | $94.13 | $103.35 | +53.45% |
| May, 2026 | $84.40 | $86.61 | $86.54 | +38.98% |
| June, 2026 | $51.58 | $57.78 | $71.99 | -15.06% |
| July, 2026 | $27.66 | $28.41 | $42.34 | -54.46% |
| August, 2026 | $50.18 | $7.5854 | $47.24 | -17.38% |
| September, 2026 | $150.10 | $44.43 | $132.84 | +147.16% |
| October, 2026 | $157.56 | $159.02 | $179.29 | +159.44% |
| November, 2026 | $139.36 | $141.70 | $153.27 | +129.47% |
| December, 2026 | $128.06 | $130.27 | $136.45 | +110.87% |
Conmed Corp Stock (CNMD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Conmed Corp (CNMD) is $164.79, with a high forecast of $286.94 and a low forecast of $42.63. This indicates an +171.35% increase from the last price of $60.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $92.11 | $98.31 | $114.86 | +51.67% |
| February, 2027 | $66.54 | $67.46 | $82.09 | +9.57% |
| March, 2027 | $62.21 | $42.63 | $62.51 | +2.44% |
| April, 2027 | $204.71 | $76.35 | $187.45 | +237.08% |
| May, 2027 | $212.25 | $214.75 | $233.12 | +249.50% |
| June, 2027 | $192.19 | $192.54 | $204.71 | +216.47% |
| July, 2027 | $176.27 | $177.55 | $185.59 | +190.25% |
| August, 2027 | $141.61 | $146.46 | $167.17 | +133.18% |
| September, 2027 | $103.94 | $104.85 | $132.50 | +71.15% |
| October, 2027 | $96.48 | $77.68 | $99.12 | +58.86% |
| November, 2027 | $111.23 | $108.26 | $114.20 | +83.16% |
| December, 2027 | $263.73 | $260.18 | $286.94 | +334.27% |
Conmed Corp Stock (CNMD) Price Forecast for 2028
In 2028, Conmed Corp (CNMD) is projected to reach an average price of $226.75, with a high projection of $340.77 and a low estimate of $112.73. This indicates an +273.38% rise from the last price of $60.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $240.54 | $240.89 | $255.40 | +296.09% |
| February, 2028 | $216.81 | $223.02 | $233.16 | +257.01% |
| March, 2028 | $182.92 | $187.77 | $211.22 | +201.20% |
| April, 2028 | $141.89 | $144.76 | $173.03 | +133.64% |
| May, 2028 | $111.19 | $112.73 | $136.53 | +83.09% |
| June, 2028 | $139.88 | $132.06 | $147.69 | +130.33% |
| July, 2028 | $322.11 | $314.79 | $340.77 | +430.40% |
| August, 2028 | $288.89 | $289.24 | $312.51 | +375.70% |
| September, 2028 | $262.04 | $268.25 | $280.73 | +331.48% |
| October, 2028 | $232.87 | $240.00 | $255.66 | +283.45% |
| November, 2028 | $180.07 | $182.94 | $223.85 | +196.51% |
| December, 2028 | $146.24 | $147.78 | $173.93 | +140.81% |
Conmed Corp Stock (CNMD) Price Forecast for 2029
The 2029 price forecast for Conmed Corp Stock (CNMD) is $307.38 on average, with a high prediction of $448.43 and a low estimate of $166.33. This represents an +406.14% increase from the previous price of $60.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $171.50 | $166.33 | $181.17 | +182.40% |
| February, 2029 | $383.99 | $369.40 | $394.60 | +532.28% |
| March, 2029 | $339.59 | $346.46 | $373.00 | +459.17% |
| April, 2029 | $317.84 | $320.18 | $329.36 | +423.36% |
| May, 2029 | $274.96 | $282.09 | $306.86 | +352.75% |
| June, 2029 | $225.08 | $236.87 | $265.16 | +270.62% |
| July, 2029 | $204.15 | $205.31 | $214.54 | +236.16% |
| August, 2029 | $203.42 | $182.83 | $214.66 | +234.96% |
| September, 2029 | $437.03 | $424.01 | $448.43 | +619.63% |
| October, 2029 | $403.39 | $405.65 | $425.27 | +564.24% |
| November, 2029 | $363.84 | $366.19 | $380.17 | +499.11% |
| December, 2029 | $331.73 | $338.20 | $352.08 | +446.24% |
Conmed Corp Stock (CNMD) Price Forecast for 2030
Conmed Corp Stock (CNMD) is expected to reach an average price of $386.98 in 2030, with a high forecast of $556.08 and a low forecast of $217.88. This signifies an +537.21% surge from the last price of $60.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $264.04 | $275.83 | $316.34 | +334.78% |
| February, 2030 | $239.98 | $241.14 | $252.72 | +295.16% |
| March, 2030 | $244.54 | $217.88 | $248.14 | +302.66% |
| April, 2030 | $503.46 | $235.94 | $502.25 | +729.02% |
| May, 2030 | $453.31 | $455.56 | $488.35 | +646.43% |
| June, 2030 | $420.69 | $421.70 | $429.30 | +592.72% |
| July, 2030 | $389.99 | $392.20 | $408.56 | +542.18% |
| August, 2030 | $320.98 | $327.63 | $372.10 | +428.53% |
| September, 2030 | $283.95 | $284.70 | $298.92 | +367.56% |
| October, 2030 | $277.24 | $252.93 | $281.62 | +356.51% |
| November, 2030 | $557.29 | $267.86 | $556.08 | +817.65% |
| December, 2030 | $512.44 | $513.90 | $541.39 | +743.81% |
1.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):